title: Prevalence of virulence genes among bulgarian nosocomial and cystic fibrosis isolates of pseudomonas aeruginosa.
abstract: The aim of this study was to evaluate the prevalence of some virulence genes among 202 Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients (n=42) and non-CF in-patients (n=160) and to analyze the values according to the patient groups, infection localization and antimicrobial resistance. The following frequencies in all studied strains were established: algD (encoding GDP-mannose 6-dehydrogenase AlgD) - 91.1%, pilB (type IV fimbrial biogenesis protein PilB) - 23.8%, nan1 (neuraminidase) - 21.3%, lasB (elastase LasB) - 100%, plcH (haemolytic phospholipase C precursor) - 91.6%, exoS (exoenzyme S) - 62.4%, and exoU (exoenzyme U) - 30.2%. The prevalence of nan1 was significantly higher (P<0.01) in CF isolates (38.1%) than that in non-CF isolates (16.9%). The nan1-positive CF strains were cultured from 16 patients with recurrent lung exacerbations. This study revealed a statistically significant difference (P<0.01) between the portion of multidrug-resistant (MDR) nosocomial P. aeruginosa strains containing a large number (≥5) of virulence genes (38.1%) and the respective part of non-MDR isolates (17.6%). Moreover, pilB, exoU and nan1 manifested a higher spread (P<0.001) among MDR than in non-MDR strains (respectively, 39.1% vs. 13.2%; 40.2% vs. 17.7% and 26.1% vs. 4.4%). In conclusion, the dissemination of nan1 in CF isolates was moderate and correlated with the lower proportion of patients with lung exacerbations. The molecular-genetic detection of this gene may be used as an indirect measure of CF pulmonary disease evolution. Simultaneous determination of virulence factors and antimicrobial resistance is the contemporary approach for examination of the microbiological aspects of infections caused by P. aeruginosa.
authors.affiliation: Department of Medical Microbiology , Medical University of Sofia , Bulgaria.
authors.forename: Ivan
authors.initials: I
authors.lastname: Mitov
authors.forename: Tanya
authors.initials: T
authors.lastname: Strateva
authors.forename: Boyka
authors.initials: B
authors.lastname: Markova
keywords: Pseudomonas aeruginosa; cystic fibrosis isolates; non-cystic fibrosis isolates; polymerase chain reaction; virulence genes
references.citation: Nature. 2003 Nov 20;426(6964):306-10
references.pmid: 14628055
references.citation: J Med Microbiol. 2009 May;58(Pt 5):690-692
references.pmid: 19369536
references.citation: Prog Drug Res. 1991;37:91-105
references.pmid: 1763187
references.citation: J Clin Microbiol. 2004 Dec;42(12):5783-92
references.pmid: 15583313
references.citation: Microbiology (Reading). 1999 Oct;145 ( Pt 10):2857-62
references.pmid: 10537207
references.citation: J Med Microbiol. 2004 Jan;53(Pt 1):73-81
references.pmid: 14663109
references.citation: Ann Microbiol (Paris). 1980 Nov-Dec;131B(3):209-22
references.pmid: 6781392
references.citation: Clin Microbiol Infect. 2005 Sep;11(9):690-703
references.pmid: 16104983
references.citation: Antimicrob Agents Chemother. 2003 May;47(5):1681-8
references.pmid: 12709340
references.citation: Nature. 2001 Oct 25;413(6858):860-4
references.pmid: 11677611
references.citation: J Chemother. 2008 Dec;20(6):714-20
references.pmid: 19129069
references.citation: J Infect Dis. 2003 Dec 1;188(11):1695-706
references.pmid: 14639541
references.citation: Int J Med Microbiol. 2002 Jul;292(2):107-13
references.pmid: 12195733
references.citation: Chest. 2001 Feb;119(2 Suppl):397S-404S
references.pmid: 11171776
references.citation: Infect Immun. 2000 May;68(5):2916-24
references.pmid: 10768989
references.citation: Microbiology (Reading). 2001 Oct;147(Pt 10):2659-2669
references.pmid: 11577145
references.citation: Crit Care Med. 2002 Mar;30(3):521-8
references.pmid: 11990909
references.citation: Ann Clin Microbiol Antimicrob. 2006 Jun 08;5:14
references.pmid: 16762075
references.citation: Microbes Infect. 2002 May;4(6):613-20
references.pmid: 12048030
references.citation: Infect Immun. 2000 Jul;68(7):3998-4004
references.pmid: 10858214
references.citation: Emerg Infect Dis. 1998 Oct-Dec;4(4):551-60
references.pmid: 9866731